Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). (Q37832624)
Jump to navigation
Jump to search
scientific article published on February 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). |
scientific article published on February 2011 |
Statements
1 reference
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). (English)
1 reference
Ignace Vergote
1 reference
Gunnar Kristensen
1 reference
Gordon John Sampson Rustin
1 reference
Elizabeth Eisenhauer
1 reference
Michael Quinn
1 reference
Tate Thigpen
1 reference
Andreas du Bois
1 reference
Anders Jakobsen
1 reference
Satoru Sagae
1 reference
Kathryn Greven
1 reference
Mahesh Parmar
1 reference
Michael Friedlander
1 reference
Andres Cervantes
1 reference
Jan Vermorken
1 reference
Gynecological Cancer Intergroup
1 reference
1 February 2011
1 reference
1 reference
21
1 reference
2
1 reference
419-423
1 reference
Identifiers
1 reference
1 reference